PTLA

Portola Pharmaceuticals, Inc. Competitors

$25.31
*  
0.60
2.32%
Get PTLA Alerts
*Delayed - data as of Aug. 21, 2014  -  Find a broker to begin trading PTLA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PTLA After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Competitor Industry: Major Pharmaceuticals

Portola Pharmaceuticals, Inc.
CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Pozen, Inc.
POZN: NASDAQ-GS
$ 7.72 0.07 ▲ 221,420 $ 7.87
$ 7.66
$ 9.73
$ 4.0278
NE 238,200,600
Prana Biotechnology Ltd
PRAN: NASDAQ-CM
$ 2.10 -0.07 ▼ 456,311 $ 2.25
$ 2.08
$ 13.29
$ 1.47
NE 85,707,300
Prestige Brand Holdings, Inc.
PBH: NYSE
$ 34.62 -0.17 ▼ 217,151 $ 34.96
$ 34.12
$ 36.69
$ 24.94
26.43 1,799,236,020
Prima BioMed Ltd
PBMD: NASDAQ-GM
$ 1.1001 unch 1,600 $ 1.1001
$ 1.10
$ 2.59
$ .82
NE 39,092,054
Progenics Pharmaceuticals Inc.
PGNX: NASDAQ-GS
$ 5.12 -0.06 ▼ 859,278 $ 5.29
$ 5.04
$ 7.45
$ 3.1001
NE 356,126,720
ProPhase Labs, Inc.
PRPH: NASDAQ-GM
$ 1.58 0.02 ▲ 5,800 $ 1.59
$ 1.56
$ 2.98
$ 1.49
NE 26,322,800
Prosensa Holding N.V.
RNA: NASDAQ-GS
$ 9.06 -0.34 ▼ 75,154 $ 9.50
$ 8.941
$ 26
$ 3.431
NE 325,552,980
Prothena Corporation plc
PRTA: NASDAQ-GS
$ 21.25 0.15 ▲ 364,011 $ 21.70
$ 20.70
$ 49.24
$ 16.48
NE 581,548,750
Provectus Biopharmaceuticals, Inc.
PVCT: AMEX
$ .9099 0.01 ▲ 286,782 $ .95
$ .8918
$ 3.75
$ .30
NE 160,722,916
PTC Therapeutics, Inc.
PTCT: NASDAQ-GS
$ 29.79 -1.22 ▼ 186,414 $ 31.97
$ 29.52
$ 34.65
$ 13.15
NE 895,904,460
Puma Biotechnology Inc
PBYI: NYSE
$ 237.41 -12.50 ▼ 418,610 $ 251.88
$ 234.62
$ 263.34
$ 33.70
NE 7,150,314,380
QLT Inc.
QLTI: NASDAQ-GS
$ 5.56 0.26 ▲ 106,515 $ 5.72
$ 5.30
$ 7.10
$ 4.06
NE 284,015,920
Raptor Pharmaceutical Corp.
RPTP: NASDAQ-GM
$ 11.08 -0.30 ▼ 291,457 $ 11.45
$ 11.01
$ 17.72
$ 7.12
NE 693,796,360
Receptos, Inc.
RCPT: NASDAQ-GS
$ 46.45 -0.15 ▼ 214,345 $ 46.54
$ 45.50
$ 55
$ 15.21
NE 1,236,080,950
Recro Pharma, Inc.
REPH: NASDAQ-CM
$ 5.70 -0.19 ▼ 93,241 $ 5.82
$ 5.65
$ 9.88
$ 5.01
NE 43,935,600
Redhill Biopharma Ltd.
RDHL: NASDAQ-CM
$ 13.851 0.01 ▲ 363 $ 13.851
$ 13.85
$ 21
$ 9.01
NE 121,126,995
Regado BioSciences, Inc.
RGDO: NASDAQ-CM
$ 2.83 -0.03 ▼ 139,729 $ 2.89
$ 2.76
$ 14.10
$ 2.22
NE 95,113,470
Regeneron Pharmaceuticals, Inc.
REGN: NASDAQ-GS
$ 341.51 -3.77 ▼ 389,668 $ 347
$ 341.1101
$ 353.05
$ 230.70
97.3 33,768,508,800
Regulus Therapeutics Inc.
RGLS: NASDAQ-GM
$ 6.91 -0.10 ▼ 59,000 $ 7.07
$ 6.82
$ 11.88
$ 5.404
NE 299,596,870
Reliv' International, Inc.
RELV: NASDAQ-GS
$ 1.18 0.04 ▲ 11,572 $ 1.18
$ 1.1541
$ 3.50
$ 1.14
39.33 14,945,880
Relypsa, Inc.
RLYP: NASDAQ-GS
$ 26.04 -0.61 ▼ 157,177 $ 26.75
$ 25.87
$ 52.74
$ 11.55
NE 881,323,800
Retrophin, Inc.
RTRX: NASDAQ-GM
$ 12.22 0.09 ▲ 200,633 $ 12.35
$ 11.97
$ 24.25
$ 9.09
NE 311,426,700
Revance Therapeutics, Inc.
RVNC: NASDAQ-GM
$ 23.73 -0.87 ▼ 101,644 $ 24.71
$ 23.60
$ 39.86
$ 21
NE 557,014,290
Rexahn Pharmaceuticals, Inc.
RNN: AMEX
$ .70 -0.01 ▼ 363,815 $ .715
$ .693
$ 1.85
$ .36
NE 124,777,100
Rigel Pharmaceuticals, Inc.
RIGL: NASDAQ-GS
$ 2.54 -0.09 ▼ 294,499 $ 2.67
$ 2.52
$ 5
$ 2.31
NE 222,328,740